Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant OC126 (Abagovomab Biosimilar) anticorps

L’anticorps anti-OC126 (Abagovomab Biosimilar) Monoclonal Human est utilisé pour la détection de OC126 (Abagovomab Biosimilar) dans des échantillons de Souris. Il a été validé pour ELISA et WB.
N° du produit ABIN7538052
220,00 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 3 à 4 jours ouvrables

Aperçu rapide pour Recombinant OC126 (Abagovomab Biosimilar) anticorps (ABIN7538052)

Antigène

OC126 (Abagovomab Biosimilar)

Type d'anticorp

Recombinant Antibody

Reactivité

Souris

Hôte

  • 1
Human

Clonalité

  • 1
Monoclonal

Conjugué

  • 1
Cet anticorp OC126 (Abagovomab Biosimilar) est non-conjugé

Application

ELISA, Western Blotting (WB)

Classe de qualité

Research Grade
  • Expression System

    Mammalian cells

    Fonction

    Abagovomab Biosimilar - Anti-idiotope of anti-Mus musculus monoclonal antibody OC126 mAb - Research Grade

    Attributs du produit

    Antibody Type: idiotypic IgG1-kappa

    Purification

    Recombinant antibody expressed in mammalien cells and purified.

    Pureté

    > 85%

    Isotype

    IgG1 kappa
  • Restrictions

    For Research Use only
  • Buffer

    PBS buffer PH7.5

    Stock

    -80 °C

    Stockage commentaire

    store at -80°C
  • Antigène

    OC126 (Abagovomab Biosimilar)

    Classe de substances

    Biosimilar

    Sujet

    Abagovomab is a murine monoclonal anti-idiotypic antibody (MW: 165-175 kDa), produced by a mouse hybridoma and generated against OC125, which serves to functionally imitate the human cancer antigen 125 (CA-125). Abagovomab has been developed by the pharmaceutical company Menarini for the treatment of ovarian cancer. It (ab2) shows high affinity for the paratope of ab1, and binding of ab2 to Ab1 is almost completely inhibited (93%) by the nominal antigen. The administration of F(ab')2 fragments of abagovomab to rats produces anti-CA-125 immunity with the production of IgG and IgM anti-anti-idiotypic antibodies (ab3) that bind both to abagovomab and CA-125. Non-MHC restricted cell-mediated cytotoxicity for NIH OVCAR3 cell lines is also demonstrated.

    Numéro CAS

    792921-10-9
Vous êtes ici:
Chat with us!